Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration said on Friday.

Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity ...

The Food and Drug Administration said on Friday that the shortage of semaglutide injection products, such as Novo Nordisk's Wegovy, has been resolved. FDA's update led to renewed uncertainty for a ...

Following the resolution of Eli Lilly’s tirzepatide shortage in October, the FDA has officially declared an end to the supply ...

The FDA has declared an end to the shortage of Novo Nordisk’s blockbuster drug semaglutide, threatening the ability for ...

A randomized, placebo-controlled trial validates a side effect frequently observed by doctors and patients. A new study from ...

The quick answer is, it's complicated. Number one, quality. Number three, delay of the product. because it's no longer ...

In this edition of The People's Pharmacy, Joe and Teresa Graedon also hear from a reader who's worried about using petroleum jelly.

Semaglutide (Wegovy and Ozempic): Originally developed for type 2 diabetes, this medication mimics the GLP-1 hormone, ...

Clinical pharmacist Dr. Christina Madison joins WIRED to answer the internet's burning questions about pharmacology and ...

When celebrities reveal their experiences with newer weight-loss drugs, there are upsides and downsides for patients and ...

Our comprehensive weight management team is here to help you successfully lose weight and support you in your weight loss journey. We can provide all the care you need, from surgeons and physician ...